INTERVET INC. Patent applications |
Patent application number | Title | Published |
20160051649 | Vaccine Against Rhipicephalus Ticks - The present invention generally relates to the fields of parasitology and immunology, and especially to a vaccine against | 02-25-2016 |
20160051352 | Apparatus for Injecting a Liquid Into Live Animals - An apparatus for injecting a liquid into live animals, comprising a cradle plate ( | 02-25-2016 |
20160038430 | Zoo-Technical Drug Delivery Device - The present invention relates to a veterinary zoo-technical drug delivery system (device) for the simultaneous release of two or more active substances, which system releases the active substances in a substantially constant ratio over a prolonged period of time. The drug delivery system can be in different forms, such as e.g. an implant, or a intravaginal device such as a helical coil, a spring or a ring. | 02-11-2016 |
20160030556 | Bovine Virus Vaccines That Are Liquid Stable - The present invention discloses liquid stable bovine vaccines that comprise a live attenuated virus, and a sugar alcohol. The present invention also discloses the manufacture of such vaccines and methods of protecting an animal by administration of such vaccines. | 02-04-2016 |
20160022694 | A Method of Improving the Efficiency of Beef Production from Bovine Animals - A method of improving the efficiency of beef production from a bovine animal which is fed multiple times per day, comprising delivering to the animal an effective dose of zilpaterol in one or more but not all of daily feedings and wherein the zilpaterol is thoroughly mixed into the feed before use. | 01-28-2016 |
20160015689 | Topical Localized Isoxazoline Formulation - This invention provides topical localized formulations comprising an isoxazoline compound and a pharmaceutically or veterinary acceptable liquid carrier vehicle comprising N,N-diethyl-3-methylbenzamide as a solvent and an improved method for controlling, and preventing parasite infestation in animals. | 01-21-2016 |
20150376577 | Methods for the Release of Virus-Like Particles - The present invention relates to methods for the release of baculovirus-expressed Virus-like Particles (VLP's) of non-enveloped viruses from insect cells. | 12-31-2015 |
20150315195 | AN IMPROVED PROCESS FOR MAKING ZILPATEROL - This invention generally relates to processes for making zilpaterol and salts thereof, as well as processes for making intermediates that, interalia, may be used to make zilpaterol and salts thereof. | 11-05-2015 |
20150306199 | Leptospira With Increased Antigenic Mass - The antigenic mass of | 10-29-2015 |
20150297704 | VACCINE TO PROTECT A RUMINANT AGAINST PNEUMONIA CAUSED BY PASTEURELLA MULTOCIDA - The present invention pertains to a vaccine comprising live attenuated | 10-22-2015 |
20150290314 | MARKER VACCINE - The present invention relates to replication-competent Bovine viral diarrhoea viruses (BVDV), Classical Swine Fever viruses (CSFV), Ovine Border Disease viruses (BDV) and atypical pestiviruses having a modification in an epitope of a viral protein, to their use as a medicament, to their use as a vaccine, to vaccines comprising such replication-competent BVDV, CSFV, atypical pestiviruses or BDV and to diagnostic tests for the detection of antibodies against such viruses and for distinguishing vaccinated animals from field infected animals | 10-15-2015 |
20150290310 | CROSS-PROTECTING SALMONELLA VACCINES - The present invention discloses that | 10-15-2015 |
20150044250 | VACCINES AGAINST CLOSTRIDIUM DIFFICILE COMPRISING RECOMBINANT TOXINS - The present invention relates to recombinant | 02-12-2015 |
20140186385 | POTOMAC HORSE FEVER ISOLATES - The present invention discloses novel isolates of | 07-03-2014 |
20130295133 | RECOMBINANT VIRUS EXPRESSING FOREIGN DNA ENCODING FELINE CD80, FELINE CD86, FELINE CD28, OR FELINE CTLA-4 AND USES THEREOF - The present invention involves a recombinant virus which comprises at least one foreign nucleic acid inserted within a non-essential region of the viral genome of a virus, wherein each such foreign nucleic acid encodes a protein. The protein which is encoded is selected from the groups consisting of a feline CD28 protein or an immunogenic portion thereof, a feline cD80 protein or an immunogenic portion thereof, a feline CD86 protein or an immunogenic portion thereof, or a feline CTLA-4 protein or an immunogenic portion thereof. The protein is capable of being expressed when the recombinant virus is introduced into an appropriate host. The present invention also involves a recombinant virus further comprising a foreign nucleic acid encoding an immunogen derived from a pathogen. The present invention also comprises recombinant viruses which are capable of enhancing an immune response in a feline. The present invention also comprises recombinant viruses which are capable of suppressing an immune response in a feline. | 11-07-2013 |
20110008389 | RECOMBINANT ATTENUATED CLOSTRIDIUM ORGANISMS AND VACCINE - The present invention discloses attenuated | 01-13-2011 |
20100166803 | EIMERIA VACCINE FOR TURKEYS - The present invention discloses a vaccine that provides protection to turkeys from coccidiosis, and methods of making and using the vaccine alone, or in combinations with other protective agents. In addition, the present invention discloses PCR primer sets that are useful in identifying the species of | 07-01-2010 |